Communicable Disease Control Program
We monitor communicable diseases, investigate outbreaks, and distribute vaccines across the region.
All invasive haemophilus influenza specimens are reportable in PARIS. Haemophilus influenza type b (Hib) requires public health follow-up, including prophylaxis for high-risk contacts. The majority of haemophilus influenza specimens are not type B; however, due to the delay in typing results, all cases of invasive specimens should be assessed for high risk contacts.
Login for internal staff materials. Contact us for access.
Reportable
Follow Up Required
Report to: Office Of Chief Medical Health Officer
Includes clinical or practice updates/changes regarding the disease for the past six months. These updates may not have been noted in the SOPs or guidelines. Any updates older than six months will be archived on this page.
We monitor communicable diseases, investigate outbreaks, and distribute vaccines across the region.